Adaptive Biotechnologies (ADPT) Preferred Stock Liabilities (2018 - 2019)

Adaptive Biotechnologies has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $561.9 million for Q2 2019.

• In Q2 2019, Preferred Stock Liabilities changed 0.23% year-over-year to $561.9 million; the TTM figure through Jun 2019 stood at $561.9 million (changed 0.23% YoY), while the FY2018 annual figure was $560.9 million, changed 0.08% from the prior year.
• Preferred Stock Liabilities came in at $561.9 million for Q2 2019 at Adaptive Biotechnologies, roughly flat from $561.2 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $561.9 million in Q2 2019 to a low of $560.7 million in Q2 2018.